You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B3GALNT2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))

Completed
  • COVID-19
  • hAd5-S-Fusion+N-ETSD
  • Placebo (0.9% (w/v) saline)
  • Newport Beach, California
    Hoag Memorial Hospital Presbyterian
Sep 1, 2023

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Long COVID Trial (LAU-7b for 3 cycles, LAU-7b for 1 cycle, then , Placebo for 3 cycles)

    Not yet recruiting
    • Long COVID
    • LAU-7b for 3 cycles
    • +2 more
    • (no location specified)
    Aug 16, 2023

    Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

    Active, not recruiting
    • Breast Neoplasms
    • Chuo Ku, Japan
    • +1 more
    Dec 19, 2022

    Liver Cirrhosis Trial (Rosuvastatin, Digoxin, Metformin hydrochlorid)

    Not yet recruiting
    • Liver Cirrhosis
    • (no location specified)
    Feb 27, 2023

    Gout Trial (ABP-671, Allopurinol, Placebo)

    Not yet recruiting
    • Gout
    • (no location specified)
    Apr 5, 2023

    Advanced Glioma, Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy Trial in Suzhou (Targeted IL-13 Ra2 UCAR-T cell

    Recruiting
    • Advanced Glioma
    • Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
    • Targeted IL-13 Rα2 UCAR-T cell injection
    • Targeted B7-H3 UCAR-T cell injection
    • Suzhou, Jiangsu, China
      The Second Affiliated Hospital of Soochow University
    Mar 2, 2023

    SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron

    Not yet recruiting
    • SARS-CoV-2 Virus
    • +2 more
    • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
    • +4 more
    • (no location specified)
    Sep 14, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

    Suspended
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 20, 2023

    Hepatitis B, Cirrhosis, Liver, Chronic Liver Disease Trial in Baltimore (Heplisav-B Injectable Product, 2-dose regimen,

    Recruiting
    • Hepatitis B
    • +2 more
    • Heplisav-B Injectable Product, 2-dose regimen
    • Heplisav-B Injectable Product, 3-dose regimen
    • Baltimore, Maryland
      Mercy Medical Center
    Aug 24, 2022

    Pharmacokinetics, Bioavailability Trial in Nottingham (Sorafenib - Period 1, XS005 Sorafenib Capsule A - Period 1, XS005

    Completed
    • Pharmacokinetics
    • Bioavailability
    • Sorafenib - Period 1
    • +8 more
    • Nottingham, United Kingdom
      Quotient Sciences
    Jul 20, 2023

    Breast Cancer Stage III Trial in Seoul (Whole breast / chest wall & regional lymph node irradiation, Internal mammary or

    Recruiting
    • Breast Cancer Stage III
    • Whole breast / chest wall & regional lymph node irradiation
    • Internal mammary or supraclavicular lymph node boost
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 8, 2023

    Chronic Hepatitis B Trial (Bepirovirsen, Placebo)

    Recruiting
    • Chronic Hepatitis B
    • Herston, Queensland, Australia
    • +7 more
    Jan 23, 2023

    Celiac Disease Trial in Saint Paul, Columbus (Cohort 1 in Part A, Cohort 2 in Part A, Cohort 3 in Part A)

    Recruiting
    • Celiac Disease
    • Cohort 1 in Part A
    • +6 more
    • Saint Paul, Minnesota
    • +1 more
    Jan 19, 2023

    Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)

    Recruiting
    • Chronic Inducible Urticaria
    • Oral EP262
    • Tampa, Florida
    • +5 more
    Sep 18, 2023

    Sleep Apnea Trial in Halifax (NovaResp MAPR System)

    Not yet recruiting
    • Sleep Apnea
    • NovaResp MAPR System
    • Halifax, Nova Scotia, Canada
      Sleep Disorders Clinic
    Aug 14, 2023

    Myopia, Hyperopia Trial in Waterloo (Lens A (fanfilcon A), Lens B (lotrafilcon B))

    Not yet recruiting
    • Myopia
    • Hyperopia
    • Lens A (fanfilcon A)
    • Lens B (lotrafilcon B)
    • Waterloo, Ontario, Canada
      Insight Eye Care
    Oct 19, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma, Refractory Trial (Pomalidomide 4 mg every day in cycle 1,

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • +2 more
    • Pomalidomide 4 mg every day in cycle 1
    • +4 more
    • (no location specified)
    Nov 16, 2022

    SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

    Recruiting
    • SARS-CoV-2 Infection
    • B/HPIV3/S-6P
    • Baltimore, Maryland
      Johns Hopkins Bloomberg School of Public Health
    Aug 30, 2023

    Stroke, Cerebral Infarction, Brain Diseases Trial in Canada (Arm Boot Camp)

    Completed
    • Stroke
    • +10 more
    • Arm Boot Camp
    • Calgary, Alberta, Canada
    • +6 more
    Feb 1, 2023

    COVID-19 Trial (Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5)

    Not yet recruiting
    • COVID-19
    • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
    • +3 more
    • (no location specified)
    Dec 22, 2022

    Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

    Recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 30, 2022

    COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

    Recruiting
    • COVID-19
    • Calgary, Alberta, Canada
    • +56 more
    Jan 12, 2023

    Adults With Severe Eosinophilic Asthma on Benralizumab.

    Active, not recruiting
    • Severe Eosinophilic Asthma
    • Survey Administration
    • Calgary, Alberta, Canada
    • +19 more
    Dec 1, 2022

    Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

    Terminated
    Has Results
    • Renal Cell Carcinoma
    • Nivolumab
    • Ipilimumab
    • Saint Louis, Missouri
    • +11 more
    Dec 15, 2022